Tech Company Financing Transactions

Adcytherix Funding Round

Pontifax Venture Capital, Dawn Biopharma and Pureos Bioventures participated in a $32 million Seed venture round for Adcytherix. The financing round was announced on 6/11/2024.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Life Sciences

Mailing Address

17 boulevard Augustin Cieussa
Marseille, 13007
France

Phone

Undisclosed

Website

www.adcytherix.com

Email Address

[email protected]

Overview

Adcytherix is a biopharmaceutical company focused on the development of novel antibody drug conjugates (ADC) to treat high unmet need diseases such as cancer. The company is led by a seasoned management team and is supported by a network of world-leading experts in the field of ADC development.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Jack Elands

        

Chief Financial Officer

Carsten Dehning

        

VP - Operations

Thierry Menguy

        

VP - R & D

Xavier Preville

        

Browse more venture capital transactions:

Prev: 6/11/2024: Astrocade AI venture capital transaction
Next: 6/11/2024: Cognigy venture capital transaction

Share this article

Where The Data Comes From

Our team works diligently to report on every notable VC transaction. VC investment data records reported here are sourced from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary